AlphaGrep UK’s UnitedHealth UNH Stock Holding History

AlphaGrep UK’s Portfolio UNH Stock Details UNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$333K	Buy	+800	New	+$297K	0.1%	412

Other funds holding UNH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AlphaGrep UK's UNH Position: Q2 2026 in Review

AlphaGrep UK reduced its UnitedHealth (UNH) stake by 75% in Q2 2026, selling an estimated $886K and leaving 781 shares worth $325K. The position accounts for 0.1% of the portfolio, ranked #429.

AlphaGrep UK first reported a position in UNH in Q4 2025 and has held it in 3 quarters since. The position peaked at $958K in Q4 2025. 3,229 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

AlphaGrep UK held 781 shares of UnitedHealth worth $325K as of Q2 2026.
AlphaGrep UK sold 2,391 UnitedHealth shares in Q2 2026, an estimated $886K.
UnitedHealth made up 0.1% of AlphaGrep UK's portfolio in Q2 2026, its #429 holding.
AlphaGrep UK first reported a position in UnitedHealth in Q4 2025 and has held it in 3 quarters since.
AlphaGrep UK's UnitedHealth position peaked at $958K in Q4 2025.
3,229 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.